Results 1 - 20 of 8,789 in Abbott Laboratories
-
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for children ...
Comment?
-
Cholesterol drugs urged for 8-year-olds
... of Medicine in Denver and pediatrician-in-chief at Children's Hospital. He has worked as a consultant to Abbott Laboratories and Merck & Co. but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
U.S.: cholesterol-fighting drugs for young children
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
New advice lowers age for cholesterol drugs
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
Docs urge cholesterol medicine for kids
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
Drugs advised to help children fight cholesterol
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co. but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
... avoid some of these heart attacks and strokes in adulthood," said Daniels, who worked as a consultant to Abbott Laboratories and Merck & Co. but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
Drugs now urged for kids with heart risk
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
Doctors Recommend Cholesterol Drugs for Children as Young as 8
... of these heart attacks and strokes in adulthood," Dr. Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
... some of these heart attacks and strokes in adulthood," Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. 5 Things ranks the five hottest breaking news stories, ...
Comment?
-
8-year-olds told to take cholesterol drugs
... some of these heart attacks and strokes in adulthood,'' Daniels said. He has worked as a consultant to Abbott Laboratories and Merck & Co., but not on matters involving their cholesterol drugs. Drug treatment would generally be targeted for kids at ...
Comment?
-
Fda Approves Xience V Drug Eluting Stent
Abbott announced that FDA approved the XIENCE V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.
Comment?
-
Health Winners & Losers: Abbott Labs
... , AstraZeneca AZN , GlaxoSmithKline GSK and Sanofi-Aventis SNY were each with 3%-plus gains. Meanwhile, Abbott Laboratories ABT shares climbed on the Food and Drug Administration approval of its Xience V, a drug-eluting stent for patients with ...
Comment?
-
Biologic Use Increases In Psoriasis Treatment
BioTrends Research Group released its third annual TreatmentTrends : Psoriasis publication, providing insight into the management of psoriasis.
Comment?
-
... Among stocks in the news Thursday were drug companies announcing regulatory approvals of new products. Abbott Laboratories ( ABT ) announced the FDA approved the Xience V Everolimus Eluting Coronary Stent System, for the treatment of coronary artery ...
Comment?
-
Baby Drinks in North America to 2011 - New Research Report on Companies and Markets
... The leading company in the market in 2006 was Mead Johnson Nutritionals. The second-largest player was Abbott Laboratories with Nestle S.A. is third place. Reasons to Purchase Discover the major quantitative trends affecting the Baby Drinks markets ...
Comment?
-
Global Baby Drinks market to 2011 - New Research Report on Companies and Markets
... in the market in 2006 was Mead Johnson Nutritionals . The second-largest player was Nestle S.A. with Abbott Laboratories is third place. Reasons to Purchase Discover the major quantitative trends affecting the Baby Drinks markets Understand ...
Comment?
-
Baby Drinks Market - Regional level to 2011 - New Research Report on Companies and Markets
... company in the market in 2006 Mead Johnson Nutritionals . The second-largest player was Nestle S.A. with Abbott Laboratories is third place. Reasons to Purchase Discover the major quantitative trends affecting the Baby Drinks markets Understand ...
Comment?
-
FDA approves Abbott's next generation stent
The U.S. Food and Drug Administration has approved Abbott Laboratories' next-generation Xience coronary stent system.
Comment?
-
Abbott Laboratories (ABT): Bill Nygren Sold out in ABT
GuruFocus Home >> Stock Ideas >> Recent Picks >> Abbott Laboratories ABT - Abbott Laboratories $81.8 Bil 11.74% 18.15 27.4% 4.61 18.59% 3.16 14.39% 2.72% 45% $2.92 1543.3 Mil Abbott Laboratories is a global ...
Comment?
Abbott Laboratories Forum
Most Popular
